CVCA Cardiac Care for Pets
is the leading choice for veterinary cardiology.
Our team of board-certified veterinary cardiologists treats small pet patients nationwide, from 27 locations coast-to-coast. In each location, our doctors bring a passion to treating the cardiac patients in their area, and share a common focus: delivering exceptional clinical care to dogs and cats, and providing unparalleled customer service to pet families.
Appointment Scheduling
Make An Appointment
For pet owners, scheduling an appointment with CVCA is easy.
- Click on the link below.
- Complete the form to tell us about your pet.
- Our staff will call you to set up an appointment with CVCA.
Refer A Patient
For primary care veterinarians, refer a patient with the online form.
- Complete the brief referral form.
- CVCA will contact the patient owner to set up an appointment.
- We will send a detailed cardiology report to you as part of your primary patient care.
Entrust your pet's care to a board-certified cardiologist!
pet owners
With early diagnosis and appropriate treatment, your pet can live a longer, healthier life with you and your family!
We also offer flexible payment plans, including:
- 6-Month Deferred Interest with CareCredit
- Interest-Free Payment Plans
- All Major Credit Cards
- Checks
- Cash
veterinary referrals
We see over 31,000 patients per year, more than any other board-certified veterinary cardiology practice worldwide.
Our veterinary cardiologists are available by phone 24 hours a day, 7 days a week for emergency and primary care veterinarians.
locations
Find a board-certified cardiologist near you at one of our 25 locations.
We have multiple locations in these states to help get your pet the care it needs.
Advancing Veterinary Cardiac Medicine
CVCA Cardiac Care for Pets has led or been a primary partner in original research to advance veterinary cardiology medicine. Currently, CVCA is partnering in two new studies relating to feline cardiac treatments.
The HALT Study
This study is for a modifying drug intervention to treat ventricular hypertrophy in cats with subclinical HCM. The study is a multi-site, blinded, randomized, placebo-controlled clinical field study to provide substantial evidence of drug effectiveness.
The VAMPIRE Study
This study is meant to evaluate the effectiveness and safety of SGLT-2 inhibition in the reversal or slowing the progression of heart muscle thickening and heart dysfunction in cats with a history of congestive heart failure secondary to hypertrophic cardiomyopathy.